Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines

Kiki Cano-Gamez(Wellcome Sanger Institute), Blagoje Soskic(Wellcome Sanger Institute), Theodoros I. Roumeliotis(Institute of Cancer Research), Ernest C. So(Institute of Cancer Research), Deborah J. Smyth(Wellcome Sanger Institute), Marta Baldrighi(Wellcome Sanger Institute), David Willé(Age UK), Nikolina Nakić(Age UK), Jorge Esparza-Gordillo(Age UK), Christopher Larminie(Age UK), Paola G. Bronson(Biogen (United States)), David F. Tough(Age UK), Wendy C. Rowan(Age UK), Jyoti S. Choudhary(Institute of Cancer Research), Gosia Trynka(Wellcome Sanger Institute)
Nature Communications
April 14, 2020
Cited by 307Open Access
Full Text

Abstract

Abstract Naïve CD4 + T cells coordinate the immune response by acquiring an effector phenotype in response to cytokines. However, the cytokine responses in memory T cells remain largely understudied. Here we use quantitative proteomics, bulk RNA-seq, and single-cell RNA-seq of over 40,000 human naïve and memory CD4 + T cells to show that responses to cytokines differ substantially between these cell types. Memory T cells are unable to differentiate into the Th2 phenotype, and acquire a Th17-like phenotype in response to iTreg polarization. Single-cell analyses show that T cells constitute a transcriptional continuum that progresses from naïve to central and effector memory T cells, forming an effectorness gradient accompanied by an increase in the expression of chemokines and cytokines. Finally, we show that T cell activation and cytokine responses are influenced by the effectorness gradient. Our results illustrate the heterogeneity of T cell responses, furthering our understanding of inflammation.


Related Papers

No related papers found

Powered by citation graph analysis